Insider Transactions in Q2 2021 at Estee Lauder Companies Inc (EL)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Fabrizio Freda President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
65,766
-32.09%
|
$20,782,056
$316.93 P/Share
|
|
Jun 30
2021
|
Fabrizio Freda President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
129,282
+38.68%
|
-
|
|
Jun 25
2021
|
Tracey Thomas Travis EVP & CFO |
SELL
Open market or private sale
|
Direct |
26,792
-46.09%
|
$8,305,520
$310.01 P/Share
|
|
Jun 25
2021
|
Tracey Thomas Travis EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,792
+31.55%
|
$2,062,984
$77.35 P/Share
|
|
Jun 11
2021
|
Zinterhofer Aerin Lauder Trust U/A/D 4/24/00 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
97,971
-17.66%
|
$29,391,300
$300.87 P/Share
|
|
Jun 10
2021
|
Jane Lauder Executive Vice President & CDO |
SELL
Open market or private sale
|
Direct |
22,752
-11.37%
|
$6,780,096
$298.78 P/Share
|
|
Jun 10
2021
|
Jane Lauder Executive Vice President & CDO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,752
+23.63%
|
$1,114,848
$49.09 P/Share
|
|
Jun 10
2021
|
Zinterhofer Aerin Lauder Trust U/A/D 4/24/00 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
150,000
-17.62%
|
$44,700,000
$298.84 P/Share
|
|
Jun 09
2021
|
Zinterhofer Aerin Lauder Trust U/A/D 4/24/00 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
72,736
-5.01%
|
$21,748,064
$299.24 P/Share
|
|
Jun 08
2021
|
Zinterhofer Aerin Lauder Trust U/A/D 4/24/00 > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
170,000
-6.88%
|
$51,340,000
$302.1 P/Share
|
|
Jun 07
2021
|
Zinterhofer Aerin Lauder Trust U/A/D 4/24/00 > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
675,000
+50.0%
|
-
|
|
Jun 07
2021
|
Irvine O Hockaday Jr Director |
SELL
Open market or private sale
|
Direct |
2,740
-100.0%
|
$827,480
$302.23 P/Share
|
|
Jun 01
2021
|
Fabrizio Freda President and CEO |
SELL
Open market or private sale
|
Direct |
32,209
-29.86%
|
$9,920,372
$308.0 P/Share
|
|
May 27
2021
|
Rose Marie Bravo Director |
SELL
Open market or private sale
|
Direct |
4,234
-100.0%
|
$1,287,136
$304.23 P/Share
|
|
May 27
2021
|
Rose Marie Bravo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,234
+40.52%
|
$707,078
$167.19 P/Share
|
|
May 24
2021
|
Sara E Moss Vice Chairman |
BUY
Bona fide gift
|
Indirect |
5,345
+10.53%
|
-
|
|
May 24
2021
|
Sara E Moss Vice Chairman |
SELL
Bona fide gift
|
Indirect |
5,345
-26.73%
|
-
|
|
May 11
2021
|
Cedric Prouve Group President, International |
SELL
Bona fide gift
|
Direct |
67,800
-28.55%
|
-
|
|
May 11
2021
|
Leonard A. Lauder 2013 Revocable Trust Director |
SELL
Bona fide gift
|
Direct |
150,000
-57.23%
|
-
|
|
May 11
2021
|
Leonard A. Lauder 2013 Revocable Trust Director |
BUY
Bona fide gift
|
Direct |
75,000
+50.0%
|
-
|
|
May 10
2021
|
Lynn Forester Director |
SELL
Open market or private sale
|
Direct |
880
-10.26%
|
$266,640
$303.15 P/Share
|
|
May 10
2021
|
Lynn Forester Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,576
+34.79%
|
$260,832
$57.53 P/Share
|
|
May 07
2021
|
Tracey Thomas Travis EVP & CFO |
SELL
Open market or private sale
|
Direct |
26,792
-46.09%
|
$8,171,560
$305.01 P/Share
|
|
May 07
2021
|
Tracey Thomas Travis EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,792
+31.48%
|
$2,062,984
$77.35 P/Share
|
|
May 07
2021
|
Richard D Parsons Director |
SELL
Open market or private sale
|
Direct |
2,329
-100.0%
|
$703,358
$302.36 P/Share
|
|
May 07
2021
|
Richard D Parsons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,329
+50.0%
|
$333,047
$143.39 P/Share
|
|
May 07
2021
|
John Demsey Group President |
SELL
Open market or private sale
|
Direct |
1,500
-14.97%
|
$448,500
$299.9 P/Share
|
|
May 05
2021
|
Ronald S Lauder Chairman, Clinique Labs, LLC |
SELL
Open market or private sale
|
Direct |
1,700,000
-100.0%
|
$496,400,000
$292.0 P/Share
|
|
May 04
2021
|
Charlene Barshefsky Director |
SELL
Open market or private sale
|
Indirect |
910
-2.06%
|
$266,630
$293.54 P/Share
|
|
May 04
2021
|
Charlene Barshefsky Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,576
+9.39%
|
$260,832
$57.53 P/Share
|
|
May 04
2021
|
John Demsey Group President |
SELL
Open market or private sale
|
Direct |
1,000
-9.08%
|
$296,000
$296.02 P/Share
|
|
May 04
2021
|
Michael O'Hare EVP-Global Human Resources |
SELL
Open market or private sale
|
Direct |
2,183
-90.84%
|
$641,802
$294.65 P/Share
|
|
May 04
2021
|
Ronald S Lauder Chairman, Clinique Labs, LLC |
BUY
Conversion of derivative security
|
Direct |
1,700,000
+50.0%
|
-
|
|
Apr 09
2021
|
Sara E Moss Vice Chairman |
SELL
Open market or private sale
|
Direct |
12,000
-100.0%
|
$3,600,000
$300.0 P/Share
|
|
Apr 09
2021
|
Sara E Moss Vice Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+50.0%
|
$1,284,000
$107.95 P/Share
|
|
Apr 09
2021
|
Tracey Thomas Travis EVP & CFO |
SELL
Open market or private sale
|
Direct |
22,924
-42.25%
|
$6,877,200
$300.01 P/Share
|
|
Apr 09
2021
|
Tracey Thomas Travis EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,924
+29.7%
|
$1,742,224
$76.23 P/Share
|